Arialys Therapeutics
Clinical trials sponsored by Arialys Therapeutics, explained in plain language.
-
First human test of brain disease 'Shield' drug begins
Disease control OngoingThis is the first study in people to test the safety of a new drug called ART5803. It is being tested in 64 healthy volunteers to see how their bodies handle it and to check for side effects. The drug is designed to block harmful antibodies that cause a serious brain inflammation…
Phase: PHASE1 • Sponsor: Arialys Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
First human test for promising brain disease drug begins
Disease control OngoingThis is a very early study to check the safety of a new drug called ART5803 in healthy people. The drug is being developed to treat a serious brain inflammation disease. Researchers want to see how the drug behaves in the body when given after a common treatment called IVIG.
Phase: PHASE1 • Sponsor: Arialys Therapeutics • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC